HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Wendremaire Selected Research

ethyl 4- (4- ((2- hydroxy- 3- (4- hydroxy- 3- ((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoate

3/2010SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Wendremaire Research Topics

Disease

1Myocardial Infarction
06/2014
1Pain (Aches)
06/2014
1Thrombocytopenia (Thrombopenia)
06/2014
1Hepatocellular Carcinoma (Hepatoma)
06/2014
1Chorioamnionitis
03/2010
1Inflammation (Inflammations)
03/2010

Drug/Important Bio-Agent (IBA)

1Dihydrotachysterol (AT 10)IBA
06/2014
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
06/2014
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2014
1Metalloproteases (Metalloproteinases)IBA
03/2010
1CollagenIBA
03/2010
1LipopolysaccharidesIBA
03/2010
1Matrix Metalloproteinases (MMPs)IBA
03/2010
1ethyl 4- (4- ((2- hydroxy- 3- (4- hydroxy- 3- ((methylsulfonyl)amino)phenoxy)propyl)amino)cyclohexyl)benzoateIBA
03/2010